All Pharma articles
See all articles with this subject.
-
HSJ InteractiveReimagining medicines optimisation: A call to action for reducing health inequalities
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only. In July 2024, HSJ Advisory, in partnership with Aspire Pharma Ltd, brought together NHS and pharmacy ...
-
HSJ AwardsHSJ Patient Safety Awards 2024: Improving Medicines Safety Award
WINNER NHS Greater Manchester, Health Innovation Manchester, NIHR Greater Manchester Patient Safety Research Collaboration: Scaling a Local Safety Medication Dashboard (SMASH) Programme to Benefit the 2.8 Million Population of Greater Manchester
-
NewsPrimary care excluded from drug deal because GPs and commissioners cannot be trusted
Primary care will continue to be denied access to drugs whose price has been reduced as part of a deal between government and the pharmaceutical industry because “commissioners, doctors and pharmacists” cannot be trusted with confidential information about costs, according to an NHS England letter.
-
NewsCancer treatment ‘biased against ethnic minorities’
A type of cancer treatment used in the NHS appears to be biased against non white European patients, research has found.
-
HSJ PartnersHow better data and technology can improve our approach to medicines optimisation
Meera Parkash, a clinical facilitator at Optum® and former head of medicines management at Bexley Clinical Commissioning Group, describes the obstacles holding back medicines optimisation in primary care — and explains why technology can be a catalyst for change
-
News‘Deficient’ processes and ‘poor’ safety culture found in trust review
A trust’s drugs control department was found to have a “significant under-appreciation of safety” and “a culture of unwillingness”, after it lost track of at least two bags of fentanyl.
-
NewsHospital forced to close sterile unit after leak
A trust has been forced to close its sterile drugs production unit due to “increasing infrastructure weakness”, risking a £3m annual bill for purchasing the medicines.
-
Expert BriefingImPatient: Dealing with Big Pharma and Big Everything
Patient (Lived Experience) Leadership is about those affected by life-changing illness, injury or disability who want to influence change through being equal partners in decision-making. In this monthly expert briefing, patient leadership champion David Gilbert picks out the most significant developments in a field of increasing relevance to the NHS.
-
NewsRevealed: ‘Postcode lottery’ for £645m recovery programme
There is a seven-fold variation between integrated care systems in the uptake of a flagship government primary care access scheme, data has revealed.
-
Expert BriefingPatient Safety Watch: Maternity strategy is needed, but it mustn’t be rushed
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chief executive James Titcombe.
-
CommentThe three reasons why the push to increase the role of pharmacies is being undermined
William Pett, head of policy, public affairs and research at Healthwatch England says the public welcomes the launch of Pharmacy First. This positive news sends a clear message to healthcare leaders on addressing access barriers.
-
HSJ PartnersBuilding strong and robust NHS partnerships
Providing NHS trusts across the UK with reliable and proven specialist pharmacy services, LloydsPharmacy Healthcare Services Limited looks to the future and the ever-changing needs on the NHS
-
HSJ InteractiveHSJ webinar discussed how to best manage the increasing number of patients seeking obesity treatment
In association with An on-demand version of this webinar is available. The arrival of highly effective new drugs to help patients with obesity lose weight has led to enormous media interest and many patients seeking help. But they may be disappointed: while NICE estimates that nearly 10 ...
-
Expert BriefingPatient Safety Watch: What can be done to improve duty of candour?
HSJ hosts the Patient Safety Watch newsletter, written by Patient Safety Watch chief executive James Titcombe.
-
Expert BriefingImPatient: Asking good questions and getting organised
Patient (Lived Experience) Leadership is about those affected by life-changing illness, injury or disability who want to influence change through being equal partners in decision-making. In this monthly expert briefing, patient leadership champion David Gilbert picks out the most significant developments in a field of increasing relevance to the NHS.
-
CommentClinical homecare needs to be properly regulated
Clinical homecare could offer a solution to some key NHS challenges, says Mark Hackett. With a focus on governance and strategic thinking, increased uptake could be transformative for patient experience, the NHS and society.
-
HSJ PartnersPharmacists have the ideas and inspiration to change the NHS for the better – but we must listen and act on their concerns
Martin McShane, medical director at Optum UK, describes the key findings from an HSJ roundtable discussion on how pharmacy can support efforts to address health inequalities
-
News‘Horrifying’ failure to provide safety warnings for high-risk medicine
Concerns have been raised that patients may not be receiving “vital” safety information after HSJ discovered a high-risk medication was frequently not being dispensed as originally packaged.
-
HSJ PartnersDigitally transforming diagnostic pathways as NHS ramps up GP Direct Access to CDC resources
The advent of community diagnostic centres is welcome. But without their integration into pathways, systems and patients will struggle to benefit. Innovative Scottish company Lenus Health has evidenced a better way, using its plug-in digital diagnostic pathways to coordinate and automate the patient diagnostic journey from referral to treatment plan
-
CommentThe rationing of cancer care must be addressed
Amid positive strides in addressing oncology capacity challenges, the new health secretary must now commit to sustained action, clear funding, and strategic technology integration for lasting improvements in cancer care, writes Tom Roques